Literature DB >> 11297217

Is there a relationship between influenza vaccinations and risk of melanoma? A population-based case-control study.

G Mastrangelo1, C R Rossi, A Pfahlberg, V Marzia, A Barba, M Baldo, E Fadda, G Milan, K F Kölmel.   

Abstract

The aim of the present case-control study was to ascertain whether, in adults, yearly repeated anti-influenza vaccinations (AIV) enhance protection against cutaneous melanoma (CM), as do repeated febrile infections. Ninety-nine new cases of histologically confirmed CM and 104 healthy controls (matched to cases for sex, age, and skin colour) selected from the general population were examined in order to ascertain their skin type, the number of nevi on both arms, and the intensity of freckles on the face and the arms; in these subjects, a structured questionnaire was used to obtain information on age, sex, education, social class, exposure and susceptibility to sunlight, history of febrile infectious diseases, and vaccinations. The odds ratio (OR) and the 95% confidence interval (CI) were estimated by commonly used methods and by fitting models of logistic regression. The risk of CM was reduced in subjects with a history of febrile (temperature above 38.5 degrees C) infections in the 5 years prior to CM surgery (cases) or interview (controls), but was increased in those with voluntary exposure to sunlight in tropical countries. By holding the above factors constant at logistic regression analysis, it was found that a history of repeated AIV (3-5 times in the last 5 years) halved the risk (OR: 0.43; CI: 0.19-1.00; p < 0.05). With the variable 'nevi on arms' included, the protective influence of repeated AIVs was observed in a similar magnitude. The inverse relationship found between melanoma and influenza vaccinations is unlikely to have depended on a bias, even if based on replies in a questionnaire, because neither the interviewers nor the interviewers were informed in advance of the working hypothesis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11297217     DOI: 10.1023/a:1007658503740

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   12.434


  19 in total

Review 1.  The pathogenesis of melanoma induced by ultraviolet radiation.

Authors:  B A Gilchrest; M S Eller; A C Geller; M Yaar
Journal:  N Engl J Med       Date:  1999-04-29       Impact factor: 91.245

Review 2.  Aggressive cutaneous malignancies following cardiothoracic transplantation: the Australian experience.

Authors:  M J Veness; D I Quinn; C S Ong; A M Keogh; P S Macdonald; S G Cooper; G W Morgan
Journal:  Cancer       Date:  1999-04-15       Impact factor: 6.860

Review 3.  Skin cancers in organ transplant recipients.

Authors:  S Euvrard; J Kanitakis; C Pouteil-Noble; A Claudy; J L Touraine
Journal:  Ann Transplant       Date:  1997       Impact factor: 1.530

4.  Concepts of fever: recent advances and lingering dogma.

Authors:  P A Mackowiak; J G Bartlett; E C Borden; S E Goldblum; J D Hasday; R S Munford; S A Nasraway; P D Stolley; T E Woodward
Journal:  Clin Infect Dis       Date:  1997-07       Impact factor: 9.079

5.  The risk of skin cancer in renal transplant recipients in Queensland, Australia. A follow-up study.

Authors:  J N Bouwes Bavinck; D R Hardie; A Green; S Cutmore; A MacNaught; B O'Sullivan; V Siskind; F J Van Der Woude; I R Hardie
Journal:  Transplantation       Date:  1996-03-15       Impact factor: 4.939

6.  Malignant melanoma in patients treated for psoriasis with methoxsalen (psoralen) and ultraviolet A radiation (PUVA). The PUVA Follow-Up Study.

Authors:  R S Stern; K T Nichols; L H Väkevä
Journal:  N Engl J Med       Date:  1997-04-10       Impact factor: 91.245

Review 7.  Melanoma and sun exposure: an overview of published studies.

Authors:  J M Elwood; J Jopson
Journal:  Int J Cancer       Date:  1997-10-09       Impact factor: 7.396

8.  Cutaneous malignant melanoma and exposure to sunlamps or sunbeds: an EORTC multicenter case-control study in Belgium, France and Germany. EORTC Melanoma Cooperative Group.

Authors:  P Autier; J F Doré; F Lejeune; K F Koelmel; O Geffeler; P Hille; J P Cesarini; D Lienard; A Liabeuf; M Joarlette
Journal:  Int J Cancer       Date:  1994-09-15       Impact factor: 7.396

9.  Body site distribution of cutaneous malignant melanoma in relationship to patterns of sun exposure.

Authors:  J M Elwood; R P Gallagher
Journal:  Int J Cancer       Date:  1998-10-29       Impact factor: 7.396

10.  Former poison gas workers and cancer: incidence and inhibition of tumor formation by treatment with biological response modifier N-CWS.

Authors:  M Yamakido; S Ishioka; K Hiyama; A Maeda
Journal:  Environ Health Perspect       Date:  1996-05       Impact factor: 9.031

View more
  4 in total

Review 1.  Overcoming cancer therapeutic bottleneck by drug repurposing.

Authors:  Zhe Zhang; Li Zhou; Na Xie; Edouard C Nice; Tao Zhang; Yongping Cui; Canhua Huang
Journal:  Signal Transduct Target Ther       Date:  2020-07-02

Review 2.  Oncolytic viruses in cancer therapy.

Authors:  Markus J V Vähä-Koskela; Jari E Heikkilä; Ari E Hinkkanen
Journal:  Cancer Lett       Date:  2007-03-23       Impact factor: 8.679

Review 3.  Vaccines for preventing influenza in healthy adults.

Authors:  Vittorio Demicheli; Tom Jefferson; Eliana Ferroni; Alessandro Rivetti; Carlo Di Pietrantonj
Journal:  Cochrane Database Syst Rev       Date:  2018-02-01

Review 4.  Current Data on Risk Factor Estimates Does Not Explain the Difference in Rates of Melanoma between Hispanics and Non-Hispanic Whites.

Authors:  Sonia Kamath; Kimberly A Miller; Myles G Cockburn
Journal:  J Skin Cancer       Date:  2016-03-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.